Sign in
Taking peopleNo phase

AN69ST Verse PS in CBP in Septic Children

Key facts

Who runs it
Children's Hospital of Fudan University
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
80 people, planned
Started
1 Oct 2025
Expected to end
31 Dec 2026
Type of study
Observational, 2 groups
Treatments tested
  • blood purification(PS)
  • blood purification(AN69ST)
Record updated
17 February 2026

Who can take part

Age
29 days to 28 years
Sex
Women and men

The registry criteria, word for word

Show all 20 criteriaShow less

Who can take part

  • Meet the 2005 diagnostic criteria for sepsis
  • Age 29 days - 18 years old
  • Sepsis-induced dysfunction of more than one organ or abnormal tissue perfusion, or septic shock
  • Diagnosis < 48 hours

Who cannot take part

  • Subject has received chemoradiotherapy or immunosuppressive therapy in the 14 days before enrollment
  • Subject is currently enrolled in an investigational drug or device trial
  • Subject has been previously enrolled in the current trial
  • Subject has received organ transplantation
  • Subject has end-stage renal disease and requires chronic dialysis
  • Subject has uncontrolled hemorrhage
  • Subject has immunodeficiency diseases
  • Subject has known sensitivity or allergy to heparin or has a history of heparin associated thrombocytopenia
  • Any other condition, that in the opinion of the investigator, would preclude the subject from being a suitable candidate for enrollment, such as end stage chronic illness with no reasonable expectation of survival to hospital discharge
  • Known hypersensitivity to hemofilter
  • HIV infection in association with a last known or suspected CD4 count of <50/mm3
  • Inability to obtain an informed consent from the subject, family member or an authorized surrogate
  • There is clinical support for non-septic shock
  • Subject has had chest compressions as part of cardiopulmonary resuscitation this hospitalization without immediate return to communicative state
  • Subject has sustained extensive third-degree burns within the past 7 days
  • Subject is expected to die within 24 hours

This trial is currently available in China.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

In septic shock, dysregulated host responses to pathogens lead to cytokine storms that damage host tissues and organs, further contributing to the development of organ dysfunction and increased mortality. For sepsis, blood purification can remove inflammatory factors in sepsis by filtration or adsorption, so as to achieve the purpose of reducing inflammatory mediators in the body. However, there are few prospective randomized controlled studies in children. Therefore, this study intends to compare the efficacy and prognosis of different membrane on children with sepsis through a perspective cohort study, so as to provide a corresponding basis for the treatment of children with sepsis blood purification.

The 2 groups in the trial

  • blood purification(AN69ST)
  • blood purification(PS)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
The Effects of a AN69ST Membrane and Polysulphone Membrane on Septic Children With Continuous Blood Purification
Record updated
17 February 2026